A carregar...

Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling

BACKGROUND: The choice between disease‐modifying drugs (DMDs) for the treatment of multiple sclerosis (MS) becomes more often a shared decision between the patient and the neurologist and MS nurse. This study aimed to assess which DMD attributes are most important for the healthcare professionals in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Expect
Main Authors: Kremer, Ingrid E. H., Evers, Silvia M. A. A., Jongen, Peter J., Hiligsmann, Mickaël
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750752/
https://ncbi.nlm.nih.gov/pubmed/28734004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hex.12599
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!